Ocular Therapeutix, Inc. (OCUL)

NASDAQ: OCUL · Real-Time Price · USD

10.36

-0.46 (-4.25%)

At close: Aug 28, 2026, 4:00 PM EDT

10.45

+0.09 (0.87%)

After-hours: Aug 28, 2026, 7:30 PM EDT

Ocular Therapeutix Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	52.06	51.95	63.72	58.44	51.49	43.52
Revenue Growth	-8.13%	-18.47%	9.03%	13.49%	18.32%	150.08%
Cost of Revenue	230.22	203.67	133.26	66.34	58	54.49
Gross Profit	-178.16	-151.72	-69.54	-7.89	-6.51	-10.97
Selling, General & Admin	135.75	118.3	91.34	74.49	72.15	67.07
Operating Expenses	135.75	118.3	91.34	74.49	72.15	67.07
Operating Income	-313.91	-270.02	-160.88	-82.38	-78.65	-78.04
Interest Expense	-11.4	-11.84	-13.58	-11.34	-7.02	-6.67
Interest & Investment Income	22.57	18.36	20.28	3.98	0.8	0.03
Other Non Operating Income (Expenses)	1.32	-2.44	-0.48	-5.19	13.84	78.12
EBT Excluding Unusual Items	-301.42	-265.94	-154.66	-94.93	-71.04	-6.55
Merger & Restructuring Charges	-	-	-1.6	-	-	-
Other Unusual Items	-	-	-37.25	14.19	-	-
Pretax Income	-301.45	-265.94	-193.51	-80.74	-71.04	-6.55
Net Income	-301.45	-265.94	-193.51	-80.74	-71.04	-6.55
Net Income to Common	-301.45	-265.94	-193.51	-80.74	-71.04	-6.55
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	214	187	158	80	77	76
Shares Outstanding (Diluted)	214	187	158	86	83	82
Shares Change	26.40%	18.31%	84.90%	3.57%	0.59%	35.24%
EPS (Basic)	-1.41	-1.42	-1.22	-1.01	-0.92	-0.09
EPS (Diluted)	-1.41	-1.42	-1.22	-1.02	-0.97	-0.98
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-255.1	-216.89	-135.97	-76.32	-63.32	-66.74
Free Cash Flow Per Share	-1.19	-1.16	-0.86	-0.89	-0.77	-0.81
Gross Margin	-	-292.04%	-109.13%	-13.51%	-12.64%	-25.20%
Operating Margin	-603.03%	-519.75%	-252.47%	-140.96%	-152.74%	-179.31%
Profit Margin	-579.09%	-511.90%	-303.67%	-138.15%	-137.95%	-15.06%
Free Cash Flow Margin	-490.06%	-417.50%	-213.37%	-130.59%	-122.96%	-153.36%
EBITDA	-308.46	-265.69	-157.1	-79.4	-76.55	-75.62
EBITDA Margin	-	-	-246.53%	-135.86%	-148.65%	-173.74%
D&A For EBITDA	5.45	4.32	3.79	2.98	2.11	2.42
EBIT	-313.91	-270.02	-160.88	-82.38	-78.65	-78.04
EBIT Margin	-	-	-252.47%	-140.96%	-152.74%	-179.31%
Revenue as Reported	52.06	51.95	63.72	58.44	51.49	43.52
Advertising Expenses	-	0.51	0.92	0.88	-	-

SEC Filings: 10-K · 10-Q